Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8540e4f0aefedf1378312fa1c5628a09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f74c3be516740e8ee88feed5fce595a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4559b2623b390942f8804aa5e27148ec |
publicationDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020173891-A1 |
titleOfInvention |
Process for the preparation of (6s)-3-[(4s)-4-cyano-2-oxo-pyrrolidin-1-yl]-6-methyl-n-(3,4,5-trifluorophenyl)-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine-5-carboxamide |
abstract |
The present invention relates to a process for synthesizing a compound (I), or pharmaceutically acceptable salt thereof, which is useful for prophylaxis and treatment of a viral disease in a patient relating to hepatitis B infection or a disease caused by hepatitis B infection. |
priorityDate |
2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |